N/A
Completed N=166
SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET
Source: ClinicalTrials.gov NCT02325531 ↗Enrolled (actual)
166
Serious AEs
—
Results posted
Dec 2022
Primary outcomePrimary: Rate Ratio of the Percent of the Clinics' Patients "Indicated" for Statin With a Guideline-appropriate Prescription for Statins — 1.09; 1.11; 1.06; 1.04 Rate ratio
Summary
The investigators propose to compare the effectiveness of 3 strategies (low, medium, high intensity) at supporting CHCs' implementation of the ALL Initiative (an intervention shown to reduce patients' cardiovascular disease (CVD) event risk), through a cluster-randomized trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate Ratio of the Percent of the Clinics' Patients "Indicated" for Statin With a Guideline-appropriate Prescription for Statins |
1.09; 1.11; 1.06; 1.04 | — |
| PRIMARY Rate Ratio of the Percent of the Clinics' Patients "Indicated" for ACE/ARB With Guideline-appropriate Prescription for ACE/ARBs |
0.95; 0.99; 0.99; 0.95 | — |
| SECONDARY Identify Clinic Characteristics Associated With the Support Strategies' Effectiveness (e.g. Decision-making Structures, Leadership Support, Team Processes I Characteristics, Readiness and Capacity for Change). |
— | — |
| SECONDARY Rate Ratio of the Change in the Percent of the Clinic's 'Indicated' Patients With Correct Intensity Statin Prescribing |
1.24; 1.35; 1.11; 1.17 | — |
Eligibility Criteria
Inclusion Criteria
- Convenience sample, all patients with Diabetes Mellitus from 30 community health clinics (CHCs) that are members of OCHIN, Inc.
Exclusion Criteria
- Patients without diagnosed DM
Data sourced from ClinicalTrials.gov (NCT02325531). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.